DSM Venturing, the corporate unit of Royal DSM N.V., has made an equity investment in Upfront Chromatography, a developer of customized industrial protein chromatography processes. According to DSM, Upfront’s downstream processing platform has the potential to contribute to all biotechnology-derived products from DSM. DSM Pharmaceutical Products provides custom manufacturing services to the pharmaceutical and biopharmaceutical industries with services in protein production and in cli...